Danaher Stock Forecast, Price & News

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 2 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Danaher stock.
View analyst ratings for Danaher or view top-rated stocks.

Wall Street analysts have given Danaher a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Danaher wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Danaher saw a decline in short interest in March. As of March 31st, there was short interest totaling 4,720,000 shares, a decline of 17.5% from the March 15th total of 5,720,000 shares. Based on an average trading volume of 2,590,000 shares, the short-interest ratio is presently 1.8 days. Currently, 0.8% of the company's shares are sold short.
View Danaher's Short Interest.

Danaher is scheduled to release its next quarterly earnings announcement on Thursday, July 22nd 2021.
View our earnings forecast for Danaher.

Danaher Co. (NYSE:DHR) announced its earnings results on Wednesday, April, 21st. The conglomerate reported $2.52 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.67 by $0.85. The conglomerate earned $6.87 billion during the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a net margin of 18.05% and a trailing twelve-month return on equity of 12.94%. Danaher's quarterly revenue was up 58.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.05 EPS.
View Danaher's earnings history.

Danaher's stock was trading at $139.37 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DHR stock has increased by 83.4% and is now trading at $255.55.
View which stocks have been most impacted by COVID-19.

Danaher announced a quarterly dividend on Wednesday, May 5th. Investors of record on Friday, June 25th will be given a dividend of $0.21 per share on Friday, July 30th. This represents a $0.84 annualized dividend and a yield of 0.33%. The ex-dividend date of this dividend is Thursday, June 24th.
View Danaher's dividend history.

Danaher pays an annual dividend of $0.84 per share and currently has a dividend yield of 0.34%. Danaher has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strock track record of dividend growth. The dividend payout ratio of Danaher is 19.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Danaher will have a dividend payout ratio of 11.63% next year. This indicates that Danaher will be able to sustain or increase its dividend.
View Danaher's dividend history.

Danaher updated its first quarter 2021 earnings guidance on Tuesday, May, 4th. The company provided EPS guidance of - for the period. The company issued revenue guidance of $6.82 billion-$6.82 billion, compared to the consensus revenue estimate of $6.13 billion.

14 analysts have issued 1 year price targets for Danaher's shares. Their forecasts range from $195.00 to $315.00. On average, they expect Danaher's stock price to reach $267.27 in the next twelve months. This suggests a possible upside of 4.6% from the stock's current price.
View analysts' price targets for Danaher or view top-rated stocks among Wall Street analysts.

27 employees have rated Danaher CEO Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among Danaher's employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Danaher include Roper Technologies (ROP), AMETEK (AME), Keysight Technologies (KEYS), Fortive (FTV), Cognex (CGNX), MKS Instruments (MKSI), Sensata Technologies (ST), Mesa Laboratories (MLAB), Senseonics (SENS), Focus Universal (FCUV), Hurco Companies (HURC), ClearSign Technologies (CLIR), Crawford United (CRAWA), Hickok (HICKA) and Sypris Solutions (SYPR).
View all of DHR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), The Home Depot (HD), The Walt Disney (DIS), Johnson & Johnson (JNJ), Adobe (ADBE), Intel (INTC), Alibaba Group (BABA), Mastercard (MA), PayPal (PYPL) and AbbVie (ABBV).

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Danaher's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.36%), Massachusetts Financial Services Co. MA (2.08%), Geode Capital Management LLC (1.39%), Edgewood Management LLC (1.16%), Northern Trust Corp (1.16%) and Bank of New York Mellon Corp (0.91%). Company insiders that own Danaher stock include Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, Joakim Weidemanis, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King.
View institutional ownership trends for Danaher.

DHR stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., JPMorgan Chase & Co., BlackRock Inc., CIBC Private Wealth Group LLC, Sumitomo Mitsui Trust Holdings Inc., Bessemer Group Inc., Bank of Nova Scotia, and APG Asset Management N.V.. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Daniel L Comas, Daniel Raskas, Joakim Weidemanis, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, and William King.
View insider buying and selling activity for Danaher or view top insider-selling stocks.

DHR stock was acquired by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Oak Ridge Investments LLC, Bank of New York Mellon Corp, Axiom Investment Management LLC, Massachusetts Financial Services Co. MA, Alliancebernstein L.P., Flossbach Von Storch AG, and Alphinity Investment Management Pty Ltd.
View insider buying and selling activity for Danaher or or view top insider-buying stocks.

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DHR stock can currently be purchased for approximately $255.55.

Danaher has a market capitalization of $182.28 billion and generates $17.91 billion in revenue each year. The conglomerate earns $3.01 billion in net income (profit) each year or $4.42 on an earnings per share basis.

Danaher employs 67,000 workers across the globe.

The following companies are subsidiares of Danaher: AB SCIEX, AB Sciex Germany GmbH, AB Sciex LLC, AB Sciex LP, AB Sciex Pte Ltd., Accu-Sort Systems, Acme Cleveland Corporation, Advanced Vision Technology, American Precision Industries, Applied Biosystems, Applitek NV, Aquatic Infomatics ULC, Aquatic Informatics, Armstrong Tools, BC Distribution BV, Beckman Coulter, Beckman Coulter Australia Pty Ltd, Beckman Coulter Biotechnology (Suzhou) Co. Ltd., Beckman Coulter Biyomedikal Urunler Sanayi ve Ticaret Limited [irketi], Beckman Coulter Canada LP, Beckman Coulter Commercial Enterprise (China) Co. Ltd., Beckman Coulter France S.A.S., Beckman Coulter G.m.b.H., Beckman Coulter Genomics Inc., Beckman Coulter Hong Kong Limited, Beckman Coulter Inc., Beckman Coulter India Private Limited, Beckman Coulter International SA, Beckman Coulter International Shanghai Trading Co., Beckman Coulter Ireland Inc., Beckman Coulter K.K., Beckman Coulter Korea Ltd., Beckman Coulter Laboratory Systems (Suzhou) Co. Ltd., Beckman Coulter Limited Liability Company, Beckman Coulter Mishima KK, Beckman Coulter Nederland B.V., Beckman Coulter Nippon GK, Beckman Coulter S.L.U., Beckman Coulter Saudi Arabia Co.Ltd., Beckman Coulter Srl, Beckman Coulter Taiwan Inc., Beckman Coulter United Kingdom Limited, Beckman Coulter de Mexico S.A. de C.V., Beckman Coulter do Brasil Ltda., Beckman Finance ApS, Beckman Holdings Ltd., BioTector Analytical Systems Ltd, Biosafe S.A., Blue Software LLC, Cepheid, Cepheid AB, Cepheid Europe SAS, Cepheid GmbH, Cepheid HBDC SAS, Cepheid UK Ltd., ChemTreat, ChemTreat Inc., ChemTreat International Inc., Cispus Hong Kong Holding Limited, Cytiva, Cytiva BioProcess R&D AB, Cytiva Biotechnology (Guangzhou) Co. Ltd., Cytiva Biotechnology (Hang Zhou) Co. Ltd., Cytiva Europe GmbH, Cytiva Sweden AB, Cytiva Sweden Holding AB, DH Europe Finance II Sarl, DH Europe Finance Sarl, DH Holding Italia SRL, DH Japan Finance Sarl, DH Life Sciences LLC, DH Netherlands BV, DH Technologies Development Pte Ltd., DHKAB Company AB, DTIL Ireland Holdings Ltd., Danaher (Shanghai) Management Co. Ltd., Danaher Hong Kong Limited, Danaher Medical ApS, Delta Consolidated Industries, Devicore Medical Products Inc., Easco Hand Tools, Esko, Esko BV, Esko Finance BV, Esko Graphics BV, Esko Software BV, FHAB Company AB, Fluke, G. Lufft Mess- und Regeltechnik GmbH, GE Biopharma, Gelman Sciences Inc., Gendex, Genetix Group, Gilbarco Veeder Root, Gilzoni Ltd., Global Life Sciences Solutions Austria GmbH & Co. KG, Global Life Sciences Solutions Germany GmbH, Global Life Sciences Solutions Korea Ltd., Global Life Sciences Solutions Manufacturing UK Ltd, Global Life Sciences Solutions New Zealand, Global Life Sciences Solutions Operations UK Ltd, Global Life Sciences Solutions Singapore Pte Ltd, Global Life Sciences Solutions USA LLC, Global Life Sciences Technologies (Shanghai) Co Ltd., Global Life Sciences Technologies Japan KK, Hach Company, Hach Lange Finance GmbH, Hach Lange GmbH, Hach Lange Sàrl, Hach Sales & Services Canada LP, Hach Ultra Japan KK, Hach Water Quality Analytical Instru. (Shanghai) Co. Ltd., HemoCue AB, HyClone Laboratories LLC, Hybritech Incorporated, Hyclone Life Sciences Solutions India Private Limited, IDBS Group, IRIS International, Imaging Sciences International, Immunotech SAS, Immunotech Sro, Intabio LLC, Integrated DNA Technologies, Integrated DNA Technologies BVBA, Integrated DNA Technologies Inc., Integrated DNA Technologies Pte. Ltd., Iris International Inc., Joslyn Holding Company LLC, KVHG GmbH, KaVo, KaVo Kerr, Kaltenbach & Voigt, Keithley Instruments, Kipp & Zonen BV, Kollmorgen, Labcyte Inc., Laetus, Leica Biosystems Imaging Inc., Leica Biosystems Melbourne Pty Ltd, Leica Biosystems Newcastle Limited, Leica Biosystems Nussloch GmbH, Leica Biosystems Richmond Inc., Leica Instruments (Singapore) Pte Limited, Leica Microsystems, Leica Microsystems (UK) Limited, Leica Microsystems CMS GmbH, Leica Microsystems Cambridge Limited, Leica Microsystems IR GmbH, Leica Microsystems Inc., Leica Microsystems Limited, Leica Microsystems Ltd. Shanghai, Leica Mikrosysteme Vertrieb GmbH, Life Sciences Holdings France SAS*, Lifschultz Industries, Linx Printing Technologies, Linx Printing Technologies Limited, MDS Analytical Technologies, Marconi Data Systems, McCrometer Inc., Microtest, Molecular Devices, Molecular Devices (Austria) GmbH, Molecular Devices LLC, Navman Wireless, Navman Wireless OEM Solutions, Nihon Pall Ltd., Nihon Pall Manufacturing Limited, Nobel Biocare, OTT Hydromet Corp, Pall, Pall (Canada) ULC, Pall (China) Co. Ltd., Pall (Schweiz) GmbH, Pall Aeropower Corporation, Pall Artelis BVBA, Pall Asia Holdings Inc., Pall Australia Pty. Ltd., Pall Austria Filter Ges.m.b.h, Pall Corporation, Pall Europe Limited, Pall Filtersystems GmbH, Pall Filtration Pte. Ltd., Pall Filtration and Separations Group Inc., Pall France SAS, Pall GmbH, Pall India Pvt. Ltd., Pall International Sarl, Pall Italia Srl, Pall Korea Ltd., Pall Life Sciences Belgium BV, Pall Life Sciences Puerto Rico LLC, Pall Manufacturing UK Limited, Pall Medistad BV, Pall Netherlands BV Irish Branch, Pall Technology UK Limited, PaloDEX, Pantone LLC, Pelton & Crane, Phenomenex, Phenomenex Inc., QHC Ireland Finance Limited, Radiometer, Radiometer Basel AG, Radiometer K.K., Radiometer Medical ApS, Radiometer Medical Equipment (Shanghai) Co. Ltd., Radiometer Turku Oy, Raytek, Reytek Corporation, SH Switzerland Finance Sarl, Sea-Bird Electronics Inc., SenDx Medical Inc., Shanghai AB Sciex Analytical Instrument Trading Co. Ltd., Sutron, Sybron Dental Specialties, TCIL Ireland Finance Ltd., Tektronix, Thomson Industries, Tianjin Bonna-Agela Technologies Co. Ltd., Trojan Technologies, Trojan Technologies Group ULC, VSS Monitoring, Videojet Do Brasil Comércio de Equipamentos Para Codificação Industrial Ltda., Videojet Technologies (Shanghai) Co. Ltd., Videojet Technologies Europe B.V., Videojet Technologies Inc., Viridor Waste Management Limited, Vision Systems Limited, Willett International, X-Ray Optical Systems Inc., X-Rite, X-Rite Europe GmbH, X-Rite Incorporated, X-Rite Switzerland GmbH, XOS, Yukon Hong Kong Holding Limited, and Zhuhai S.E.Z. Videojet Electronics Ltd..

Danaher was founded in 1984.

The official website for Danaher is www.danaher.com.

Danaher is headquartered at 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037.

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]